Results 151 to 160 of about 202,491 (298)

Predicting neurodevelopmental outcomes in Australian First Nations infants: The transdiagnostic utility of early screening tools

open access: yesDevelopmental Medicine &Child Neurology, Volume 68, Issue 3, Page 381-393, March 2026.
A culturally adapted developmental screening program (LEAP‐CP) improved First Nations families' engagement with neonatal follow‐up by almost 40%. The Motor Optimality Score‐Revised (MOS‐R), Hammersmith Infant Neurological Examination (HINE), and the Australian First Nations adaptation of the Ages and Stages Questionnaire (ASQ‐TRAK), distinguished ...
Carly Luke   +17 more
wiley   +1 more source

RISK FACTORS AND ECHOCARDIOGRAPHIC DIAGNOSIS OF PULMONARY HYPERTENSION IN CHILDREN WITH BRONCHOPULMONARY DYSPLASIA

open access: yesRUDN Journal of Medicine, 2017
Pulmonary hypertension and pulmonary heart are severe complications of broncho-pulmonary dysplasia, accompanied by poor prognosis and high mortality. Based on Doppler echocardio-graphy in 100 children with bronchopulmonary dysplasia, the frequency of ...
E A Degtyareva   +3 more
doaj   +1 more source

Mother's Own Milk and Bronchopulmonary Dysplasia: A Systematic Review and Meta-Analysis

open access: yesFrontiers in Pediatrics, 2019
Background: Bronchopulmonary dysplasia (BPD) is the most common complication of very preterm birth and can lead to lifelong health consequences. Optimal nutrition is a cornerstone in the prevention and treatment of BPD.
Eduardo Villamor-Martínez   +4 more
semanticscholar   +1 more source

Hypercapnia Effects on Lung Function

open access: yesComprehensive Physiology, Volume 16, Issue 1, February 2026.
CO2 is a signaling molecule that disrupts alveolar fluid clearance and ion transport, impairs alveolar repair, and promotes mitochondrial and endoplasmic reticulum dysfunction. It suppresses innate immunity, host defense, and inflammation, while increasing airway contractility.
Seungseo Choi   +2 more
wiley   +1 more source

Neonatal azithromycin administration to prevent infant mortality: study protocol for a randomised controlled trial. [PDF]

open access: yes, 2019
IntroductionBiannual mass azithromycin distribution to children aged 1-59 months has been shown to reduce all-cause mortality. Children under 28 days of age were not treated in studies evaluating mass azithromycin distribution for child mortality due to ...
Bagagnan, Cheik   +15 more
core  

B‐Cell Repertoire of Children With Atopic Dermatitis Exhibits Altered IgE Maturation Associated With Allergic Food Sensitization

open access: yesAllergy, Volume 81, Issue 2, Page 513-523, February 2026.
IgH repertoire sequencing of a large atopic dermatitis cohort reveal reduced IgE somatic hypermutation and increased IgE diversity associated with food allergen sensitization. Presence of a dog during the first year of life is associated with increased IgE somatic hypermutation, possibly countering the effect of food sensitization.
Kirandeep K. Gill   +18 more
wiley   +1 more source

BRONCHOPULMONARY DYSPLASIA IS A RISK FACTOR IN THE RESPIRATORY SYNCYTIAL VIRUS INFECTION IN CHILDREN

open access: yesПедиатрическая фармакология, 2009
Bronchopulmonary dysplasia, originally described as iatrogeny in extreme premature infants who had long-term artificial pulmonary ventilation, is currently viewed as a chronic lung disease in children.
D.Yu. Ovsyannikov
doaj   +2 more sources

Visual acuity outcomes up to 12 years and risk factors for visual impairment in a national cohort of extremely preterm born children – The Extremely Preterm Infants in Sweden Study (EXPRESS)

open access: yesActa Ophthalmologica, Volume 104, Issue 1, Page 65-74, February 2026.
Abstract Purpose The Extremely Preterm Infants in Sweden Study (EXPRESS) followed a national cohort of extremely preterm born (EPT, i.e. <27 weeks) children until 12 years of age. This study aimed to investigate the longitudinal development of visual acuity (VA) in children born EPT, explore the predictive value of early visual assessments, and ...
Despoina Tsamadou   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy